XRTX supply chain intelligence for XORTX Therapeutics Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
XORTX Therapeutics Inc. (XRTX) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| CONTRACT-MANUFACTURING-ORGANIZATIONS | CONTRACT-MANUFACTURING-ORGANIZATIONS | 92% | We do not control the operational processes of the contract manufacturing organizations with whom we contract, and we are dependent on these third parties to produce our product candidates in accorda… |
| THIRD-PARTY-CONTRACT-MANUFACTURERS | THIRD-PARTY-CONTRACT-MANUFACTURERS | 92% | We currently rely on a limited number of third-party contract manufacturers for all the required raw materials for our preclinical research and clinical trials, as well as for the manufacture of our … |
| ACADEMIC-INSTITUTIONS | ACADEMIC-INSTITUTIONS | 90% | We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| CLINICS | CLINICS | 90% | We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| CROS | CROS | 90% | We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| HOSPITALS | HOSPITALS | 90% | We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| OTHER-THIRD-PARTY-STRATEGIC-PARTNERS | OTHER-THIRD-PARTY-STRATEGIC-PARTNERS | 90% | We rely on entities outside of our control, which may include academic institutions, CROs, hospitals, clinics and other third-party strategic partners, to monitor, support, conduct and oversee precli… |
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| RMTI | Rockwell Medical, Inc. | 72% | ion (2015). Medical degree from University College Hospital Medical School, University of London, with Honors. Raymond Pratt, (2) Maryland, United States 75 Director December 20, 2021 Current Princip… |
| RMTI | Rockwell Medical, Inc. | 72% | Reciprocal relationship from RMTI graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from RMTI graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from RMTI g… |
| BC0911882-XORTX-PHARMA-CORP | BC0911882-XORTX-PHARMA-CORP | 62% | e or diabetic nephropathy, and patent applications filed in the U.S., EU and under the Patent Cooperation Treaty with similar claims for the treatment of metabolic syndrome, diabetes, fatty liver dis… |
| DFTX | Definium Therapeutics, Inc. | 62% | Reciprocal relationship from DFTX graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from DFTX graph: Reciprocal relationship from XRTX graph: Reciprocal relationship from DFTX g… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| XRTX-DEBT | Debt stack $15,056 | 90% | Market cache reports total debt of $15,056. |
| Holder | Name | Confidence | Evidence |
|---|---|---|---|
| XRTX-OWNER-TD-WATERHOUSE-CANADA-INC | TD Waterhouse Canada Inc. | 90% | 13F overlay lists TD Waterhouse Canada Inc. as top holder; 1 tracked holders. |